Dr. Ravi Parikh
Board-certified ophthalmologist, Dr. Ravi Parikh, is a retina specialist whose goal is to combine clinical medicine, health policy, management and better care delivery to patients in the US and abroad. Dr. Parikh’s initial inspiration to subspecialize in retina and pursue ophthalmology surprisingly occurred while performing policy research on malaria in Nigeria as a student at Vanderbilt. One evening, a middle-aged woman with uncontrolled diabetes arrived in a diabetic coma. The physicians lamented that while they could offer her life-saving treatment, they could do nothing to treat her severe vision loss from diabetes. Nearly blind, she had lost her independence. Dr. Parikh’s clinical and research experiences in retina coupled with his work and studies in public health and policy helped him to discover his interest in retina, where he combines clinical practice, health policy, and research to improve vision, prevent blindness, and impact many patients’ lives.
As a medical student at Vanderbilt and Harvard, Dr. Parikh gained an appreciation for the impact retina specialists can have on the quality of life of patients whose vision is threatened or has already deteriorated. Dr. Parikh is an expert in the treatment of retinal diseases especially the use of anti-vascular endothelial growth factor medications (anti-VEGF) for the treatment of age-related macular degeneration, diabetic retinopathy, retinal vein occlusions and all other retinal diseases. He designed and organized the largest evaluation at the time of anti-VEGF drug use in the United States, evaluating the first 10 years of use across all diagnoses, including nearly 1 million intravitreal injections from both publicly and privately insured patients across the nation. Dr. Parikh hopes to also improve care delivery to improve vision and prevent blindness.
The primary reason for Dr. Parikh’s interest in retina and ophthalmology goes back to the unfortunate woman with diabetes he met in Nigeria. Retina is where his broader interests converge to impact individual lives. He enjoys working in clinic, counseling patients on their diabetes, performing surgical lasers to prevent severe vision loss and injecting anti-VEGF agents to improve patients’ vision. His interests are focused on how we can best develop and deliver all this leading-edge care to the most patients.
- Board Certification: American Board of Ophthalmology
- Fellow: Retina, Harvard Medical School; Vitreous Retina, Macula Consultants of New York
- Residency: Ophthalmology, Yale University School of Medicine
- MD: Vanderbilt University
- MPH: Health Policy & Management, Harvard University